Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
RedHill Biopharma Reports that Opaganib Mechanism Not Impacted by Viral Spike-Protein Mutations, Including Omicron Mutations 2021-12-06 20:01
Innoforce Completes Second Tranche of Series A Financing 2021-12-06 20:00
Donisi Health Named 2021's "Future Unicorn" by E&T Magazine 2021-12-06 18:59
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies 2021-12-06 17:30
Henlius' 4th Biologics: Bevacizumab Biosimilar Hanbeitai Approved by National Medical Products Administration 2021-12-04 01:51
Starpharma signs distribution agreement for VIRALEZE™ antiviral nasal spray in Vietnam 2021-12-03 14:24
Joint CUHK-HKU study discovers efficacy of COVID-19 vaccines correlates with a probiotic bacterium, Bifidobacterium adolescentis 2021-12-02 21:00
Hohem iSteady V2 Won the 20th Shenzhen Enterprise Innovation Record (Global) 2021-12-02 17:29
Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test 2021-12-02 16:00
EZZ bolsters Board with industry veteran Glenn Cross as new Chair 2021-12-02 05:00
SOPHiA GENETICS Announces Launch of DEEP-Lung-IV Multimodal Clinical Study 2021-12-02 02:30
Dr. Aletta Schnitzler Joins TurtleTree as Chief Scientific Officer 2021-12-01 23:00
VIRALEZE™ antiviral nasal spray registered in Vietnam with launch to follow this week 2021-12-01 16:40
GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan 2021-12-01 12:03
Sai Life Sciences' pharmaceutical API manufacturing site receives Certificate of Inspection from PMDA, Japan 2021-12-01 09:00
Silexon Partners with Excelra, Deploying GOSTAR to Strengthen its AI-driven Drug Discovery and Biopharmaceutical Research Platform 2021-12-01 08:05
Lynk Pharmaceuticals Announced First Patient Dosed in Phase II Clinical Study of LNK01001 2021-12-01 08:00
EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants 2021-12-01 05:22
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results 2021-11-30 22:30
New CELLSEARCH® Circulating Multiple Myeloma Test now available to help community physicians optimize patient care 2021-11-30 22:18
1 91 92 93 94 95 211